For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

FOX NFL Insider Jay Glazer joins 'Fox & Friends' to preview Super Bowl LIX in New Orleans. Nearly 30 years after Matt Damon ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

New high-tech help for young heart patients has been approved by the U.S. Food and Drug Administration. Doctors say this will ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

The gold standard colonoscopy is still the preferred method for finding colon cancer, but on this World Cancer Day, we're hearing more about a simple blood test that could get more ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...